BREZTRI 160 ug/1
budesonide, glycopyrrolate, and formoterol fumarate · AEROSOL, METERED · AstraZeneca Pharmaceuticals LP
BREZTRI is a aerosol, metered containing budesonide, glycopyrrolate, and formoterol fumarate at 160 ug/1, taken respiratory (inhalation). Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- BREZTRI
- Generic Name
- budesonide, glycopyrrolate, and formoterol fumarate
- NDC Code (Product)
0310-4616- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 160 ug/1
- Dosage Form
- AEROSOL, METERED
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA212122
- Drug Class
- beta2-Adrenergic Agonist [EPC]; Corticosteroid [EPC]
- Marketing Start
- 07/23/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is BREZTRI used for?
BREZTRI contains budesonide, glycopyrrolate, and formoterol fumarate. It is a aerosol, metered taken respiratory (inhalation). Consult your doctor for specific uses.
Is BREZTRI a controlled substance?
BREZTRI is not classified as a controlled substance by the DEA.
What is the generic name for BREZTRI?
The generic name for BREZTRI is budesonide, glycopyrrolate, and formoterol fumarate. There are no other listed brand versions of budesonide, glycopyrrolate, and formoterol fumarate.
What is the NDC code for BREZTRI 160 ug/1?
The NDC (National Drug Code) for BREZTRI 160 ug/1 is 0310-4616, listed by AstraZeneca Pharmaceuticals LP.
Other BREZTRI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)